Las Vegas Sun

March 31, 2015

Currently: 88° — Complete forecast | Log in | Create an account

Judge: Settlements reached in 41 hepatitis C lawsuits

Settlement of cases includes contested $522 million jury verdict won by Henderson school principal


Mona Shield Payne / Special to the Sun

Henry Chanin, seated next to his wife, Lorraine, talks to reporters after an award of $500 million in punitive damages Friday, May 7, 2010. He was infected with hepatitis C during a medical procedure. A settlement announced Tuesday, Feb. 21, 2012, includes resolution of his $522.4 million total judgment.

Chanins Hold News Conference

Henry Chanin answers questions from the news media regarding his physical health during a press conference following an award of $500 million in punitive damages Friday, May 7, 2010.  Seated from left, attorney Robert Eglet, Henry Chanin, Lorraine Chanin and attorney Will Kemp. Launch slideshow »

Sun Coverage

A major breakthrough was announced today in 41 civil lawsuits that were filed as the result of the hepatitis C scare that rocked Southern Nevada in 2007 and 2008.

Clark County Court Chief Judge Jennifer P. Togliatti handled a nine-day settlement conference that brought resolutions to the cases, which involved endoscopy clinics in the Las Vegas area and two drug companies.

The terms of the settlements are not being disclosed. But the total amounts are thought to cost the companies hundreds of millions of dollars.

"This is the longest and most complicated settlement conference of my career," Togliatti said in a statement released today.

"I am extremely pleased that the parties were able to settle their differences with the assistance of the Eighth Judicial District Court," the judge said. "The parties and I spent nine days in formal meetings and informal back and forth correspondence to get these cases resolved."

The settlement includes the resolution of a $522.4 million judgment awarded to Henry Chanin, a Henderson school principal who was infected with hepatitis C during a procedure he underwent at the Desert Shadow Endoscopy Center.

Teva Parenteral Medicines Inc. and Baxter Health Care Corp. appealed the jury verdict to the Nevada Supreme Court. On Jan. 24, the high court ordered the Chanin case and 40 other pending endoscopy-related cases be resolved at a "global settlement conference" overseen by an Eighth Judicial District judge.

At the requests of the defendants' attorneys, the court excluded four endoscopy-related cases from the order, two of which had already been dismissed.

Mary Ann Price, the court's public information officer, said the breakthrough in the 41 cases amounts to "one of the largest settlements in Nevada history.”

Price said the settlements will also save millions of dollars in expenses for court time, trial time and juror time, "not to mention the heartache it will save the victims.”

"It will make a huge difference to the defendants, because they would have been in court for years," Price said. "In terms of court time and all the work that goes into this, it's all been averted."

Price said there are still some hepatitis C lawsuits not included in the global settlement conference.

"But this creates a momentum," she said. "It's good for all the parties involved, because as a victim, do you really want to wait forever to get your settlement?"

Price said the resolution averts potential years of litigation, with appeals possibly going to the U.S. Supreme Court.

"There’s not going to be any appeals or retrials," Price said "This was a big case to be resolved. The implications are big."

Other companies that were defendants in the 41 cases included the Endoscopy Center of Southern Nevada, Desert Shadow Endoscopy Center and Sicor Inc.

Join the Discussion:

Check this out for a full explanation of our conversion to the LiveFyre commenting system and instructions on how to sign up for an account.

Full comments policy

Previous Discussion: 4 comments so far…

Comments are moderated by Las Vegas Sun editors. Our goal is not to limit the discussion, but rather to elevate it. Comments should be relevant and contain no abusive language. Comments that are off-topic, vulgar, profane or include personal attacks will be removed. Full comments policy. Additionally, we now display comments from trusted commenters by default. Those wishing to become a trusted commenter need to verify their identity or sign in with Facebook Connect to tie their Facebook account to their Las Vegas Sun account. For more on this change, read our story about how it works and why we did it.

Only trusted comments are displayed on this page. Untrusted comments have expired from this story.

  1. Read today that the guy who discovered Hepatitus C has just come up with a vaccine for it. It's got to go through trials but it sounds very encouraging.

  2. Link Brian?

  3. @Brianlv : Not a vaccine ... (that's been done) ... but a promising new treatment.

    @unlv702 - here's the quote and link:

    Two new drugs -- Vertex Pharmaceuticals' telaprevir and Merck & Co.'s boceprevir -- .... Research suggests adding one of them to standard therapy can boost cure rates as high as 75 percent. While still full of side effects, they can allow some people to finish treatment in just six months. They add to the price, however, another $1,000 to $4,000 a week. Drugs that promise to work even better have begun testing.

  4. oops... my bad.. was thinking of Hep B (I had to get some kind of shots to prevent catching it when I worked as a Radiology Engineer in a Hospital) ...

    Here's the link to Hep C Vaccine research ...